Director, Media & Public Relations

Not Interested
Bookmark
Report This Job

profile Job Location:

Princeton, NJ - USA

profile Yearly Salary: $ 184000 - 230000
Posted on: 6 hours ago
Vacancies: 1 Vacancy

Job Summary

Location: Onsite (Palo Alto CA; Princeton NJ or Miami FL)

About Summit:

Ivonescimab known as SMT112 is a novel potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD-1 and VEGF.

Summit has begun its clinical development of ivonescimab in non-small cell lung cancer (NSCLC) with three active Phase III trials:

  • HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI (e.g. osimertinib).
  • HARMONi-3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
  • HARMONi-7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression.

Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summits license territories including the United States and Europe. Ivonescimab was approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.

Overview of Role:

Lead enterprise-level media relations and public-relations strategy for a fast-growing biotech. You will serve as a primary company spokesperson architect integrated earned-media campaigns and manage issues across discovery clinical regulatory and commercial milestones. Youll partner tightly with Executive Leadership Regulatory/Medical Affairs Clinical and IR to develop and advance corporate and product reputation.

Role and Responsibilities:

  • Own global media strategy: Build and execute proactive media plans (top-tier trade local) aligned to pipeline and corporate calendar; secure coverage for data readouts regulatory filings/approvals financings collaborations and leadership POVs.
  • Spokesperson & press office: Serve as day-to-day media contact; prep executives; draft/QA press materials (Q&As op-eds media briefs) and oversee measurement.
  • Issues communications: Lead rapid response for any potential negative feedback or public communication; run scenario planning and war-room protocols.
  • Data & conference moments: Orchestrate scientific congress communications (e.g. AACR ASCO ESMO) and coordinate with IR regarding press releases earnings releases and other disclosures.
  • Thought leadership: Build exec platforms across earned/owned/speaking; manage ghostwriting and social amplification (in partnership with Digital/IR).
  • Agency & budget leadership: Select and manage PR agencies; negotiate SOWs; own measurement/KPIs and quarterly dashboards.
  • Policy & advocacy alignment: Coordinate with Patient Advocacy to ensure media narratives support access and policy goals; anticipate external risks.
  • All other duties as assigned

Experience Education and Specialized Knowledge and Skills:

  • Experience: Minimum of 10 years in media relations/public relations/corporate communications including significant time in biopharma/biotech or a healthcare PR agency supporting biopharma.
  • Domain fluency: Comfort translating preclinical/clinical/regulatory topics; familiarity with GxP FDA/EMA milestones payer dynamics and scientific conferences.
  • Proven spokesperson: Track record landing tier-one coverage and managing high-stakes issues.
  • Leadership & collaboration: Executive presence; calm under pressure; excellent judgment; deft cross-functional coordination.
  • Writing & storytelling: Crisp executive writing; strong news sense; data-driven measurement mindset.
  • Bachelors degree in Communications Public Relations Life Sciences Journalism or related field required. Graduate degree preferred

The pay range for this role is $184000-$230000 annually. Actual compensation packages are based on several factors that are unique to each candidate including but not limited to skill set depth of experience certifications and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus stock benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summits Talent Acquisition team at to obtain prior written authorization before referring any candidates to Summit.


Required Experience:

Director

Location: Onsite (Palo Alto CA; Princeton NJ or Miami FL)About Summit: Ivonescimab known as SMT112 is a novel potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF ...
View more view more

Key Skills

  • Special Events
  • Blog Posts
  • Account Executives
  • Fact Sheets
  • Press Releases
  • Account Management
  • Twitter
  • Client Relationships
  • SEO
  • Content Marketing
  • Client Meetings
  • Facebook
  • ROI
  • Client Contact
  • Client Service

About Company

Company Logo

Summit is committed to leadership in resolving serious, unmet medical needs in oncology for the betterment of overall HUMAN HEALTH. Stifel Fireside Chat Patients & Caregivers Summit Latest News Committed to Optimizing Human Health Summit Therapeutics Inc. is a biopharmaceutical oncolo ... View more

View Profile View Profile